Ignite Creation Date:
2024-05-06 @ 1:23 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04001621
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-12-08
First Post:
2019-06-27
Brief Title:
Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords: